Thule Investment Management

Thule Investment Management is a venture capital and private equity firm based in Reykjavik, Iceland, that specializes in growth-stage investments within the Nordic region, with a primary focus on the life sciences and healthcare sectors. The firm is most notable for its early and lead investment in Kerecis, a pioneer in fish-skin-based biologics for tissue regeneration, which was acquired by Coloplast for $1.3 billion in 2023. Additionally, Thule has backed healthcare-adjacent technology companies like Controlant, which provides real-time monitoring for pharmaceutical supply chains, including the global distribution of COVID-19 vaccines. By providing both capital and strategic operational expertise, Thule helps Nordic innovators scale their technologies for the global market. The firm plays a central role in the Icelandic biotech ecosystem, bridging the gap between early-stage research and international commercial success.